IPBM 2025| April 4~6, 2025 | Grand Walkerhill Seoul, KOREA

Scientific Program

검색
Symposium 1.
April 3 (Fri)
09:00-10:30

Symposium 1.
Redefining Cutting Edge of Cancer Care: From Early Detection to Supportive Therapeutics

Room A
09:00-09:25 Cancer cachexia: Transition from science to practice
Jeffrey Crawford (Duke Cancer Institute, USA)
09:25-09:50 Revolutionizing Medicine in Cancer Care: Artificial Intelligence-Powered Innovations in Cancer
Kyu-Hwan Jung (Sungkyunkwan University, Korea)
09:50-10:15 Liquid Biopsy in Cancer Detection: Current Status and Future Directions
Young-Jun Jeon (Sungkyunkwan University, Korea)
10:15-10:30 Q&A and HOT DISCUSSION
Free Paper 1
April 3 (Fri)
09:00-10:30

Free Paper 1

Room B
09:00-09:15 Keynote Lecture. PRRT and the next generation radionculide therapies
TBD
Free Paper 2
April 3 (Fri)
09:00-10:30

Free Paper 2

Room C
09:00-09:15 Keynote Lecture. EUS-BD: What's new
Ichiro Yasuda (University of Toyama, Japan)
Symposium 2.
April 3 (Fri)
11:00-12:30

Symposium 2.
Short Communications: Innovations in Pancreatobiliary Endoscopy: EUS and ERCP Approaches

Room A
11:00-11:12 Multi-hole fully covered SEMS for hilar bile duct obstruction
Seok Jeong (Inha University, Korea)
11:12-11:24 Bile duct stone management in surgically altered anatomy: comparison of EUS-guided and BE-ERCP technique
Takuji Iwashita (Shiga University of Medical Science, Japan)
11:24-11:36 Breaking the obstruction: EUS-guided ileocolostomy in malignant small bowel obstruction
Se Woo Park (Hallym University, Korea)
11:36-11:48 TBD
Yu-Ting Kuo (National Taiwan University Hospital, Taiwan)
11:48-12:00 Clinical Utility of Converting PTGBD to EUS-Guided Gallbladder Drainage (EUS-GBD)
Hyung-Ku Chon (WonKwang University, Korea)
12:00-12:12 EUS-Guided Gallbladder Drainage vs. Transpapillary Stenting in High-Risk Patients: Which Is Superior?
Panida Piyachaturawat (King Chulalongkorn Memorial Hospital, Thailand)
12:12-14:24 3D-Printed Silicone Simulator for ERCP Training: Enhancing Endoscopic Education
Chang-Il Kwon (CHA University, Korea)
Meet the Expert:
April 3 (Fri)
11:00-12:30

Meet the Expert:
The future of gastroenterology is now: Real-world AI applications on the clinician's frontline

Room B
Free Paper 3
April 3 (Fri)
11:00-12:30

Free Paper 3

Room C
11:00-11:15 Keynote Lecture. TBD
Murim Choi (Seoul National University, Korea)
Special Lecture
April 3 (Fri)
13:20-13:50

Special Lecture

Room A
13:20-13:50 TBD
Lars Aabakken (Oslo University Hospital, Norway)
Live Demonstration 1
April 3 (Fri)
13:50-15:20

Live Demonstration 1

Room A+B
13:50-14:20 AIG Hospitals (India)
14:20-14:50 Seoul National University Hospital Korea)
14:50-15:20 Soon Chun Hyang University Bucheon Hospital (Korea)
Research Colloquium (Korean)
April 3 (Fri)
13:50-15:20

Research Colloquium (Korean)
Artificial Intelligence in Research and Publications: Opportunities and Challenges

Room C
Live Demonstration 2
April 3 (Fri)
15:40-17:10

Live Demonstration 2

Room A+B
15:40-16:10 TBD
16:10-16:40 Asan Medical Center (Korea)
14:40-17:10 Samsung Medical Center (Korea)
Symposium 3.
April 4 (Sat)
09:00-10:30

Symposium 3.
Fatty Pancreas: Emerging Clinical Implications in Metabolic and Pancreatic Disorders

Room A
09:00-09:20 What is the fatty pancreas and how to diagnose it?
Jong Jin Hyun (Korea University, Korea)
09:20-09:40 What is the relationship between fatty pancreas and metabolic syndrome?
Ryusuke Ookura (Osaka Metropolitan University, Japan)
09:40-10:00 Is fatty pancreas a risk factor for pancreatic cancer?
Daniel Öhlund (Umeå University, Sweden)
10:00-10:20 Is fatty pancreas a risk factor for post ERCP pancreatitis?
Dong Woo Shin (Hallym University)
10:20-10:30 Q&A
Free Paper 4
April 4 (Sat)
09:00-10:30

Free Paper 4

Room B
09:00-09:15 Keynote Lecture. Innovations and Updates in the Treatment of Benign Biliary Strictures
Douglas Faigel (Mayoclinic, USA)
Symposium 4.
April 4 (Sat)
09:00-10:30

Symposium 4.
[HBP surgery Joint Ssession] Advancing Multidisciplinary Strategies in Pancreatic Cancer

Room C
09:00-09:20 Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Toward a New Standard of Care?
Chigusa Morizane (National Cancer Center Hospital, Japan)
09:20-09:40 Optimizing Surgical Timing after Neoadjuvant Therapy: Improved Outcomes or Missed Window?
Young-Dong Yu (Korea University, Korea)
09:40-10:00 Irreversible Electroporation and Biophysical Modulation in Advanced Pancreatic Cancer
Man Deuk Kim (Yonsei University, Korea)
10:00-10:20 Contemporary Role and Emerging Directions of Radiotherapy in Pancreatic Cancer
Tae Hyun Kim (National Cancer Center, Korea)
10:20-10:30 Q&A
Plenary Session
April 4 (Sat)
10:50-11:50

Plenary Session

Room A+B
Nurse Session 1
April 4 (Sat)
10:50-12:10

Nurse Session 1

Room C
Poster Presentation
April 4 (Sat)
12:30-13:00

Poster Presentation

Grand Hall Lobby
KPBA General Assembly
April 4 (Sat)
13:10-13:50

KPBA General Assembly

Room A+B
Nurse Session 2.
April 4 (Sat)
13:10-14:10

Nurse Session 2.
Hands-on (Korean)

Grand Hall 5, 6
APBA Symposium.
April 4 (Sat)
13:50-15:20

APBA Symposium.
Redefining First-Line Biliary Drainage: EUS-BD vs. ERCP in Malignant Biliary Obstruction

Room A
13:50-14:10 ERCP or EUS-BD First? Strategic Selection in Malignant Biliary Obstruction
Yousuke Nakai (Tokyo Women's Medical University, Japan)
14:10-14:30 Safety and Feasibility: EUS-BD in Naïve Papilla vs. Surgically Altered Anatomy
Jiann-Hwa Chen (Taipei Tzu Chi University Hospital,, Taiwan)
14:30-14:50 EUS-Guided Gallbladder Drainage: Established Utility and Expanding Potential
Seong-Hun Kim (Jeonbuk National University, Korea)
14:50-15:10 The Evolving Role of EUS-BD in Reintervention and Long-Term Outcomes
Rungsun Rerknimitr (Chulalongkorn University, Thailand)
15:10-15:20 Q&A
Free Paper 5
April 4 (Sat)
13:50-15:20

Free Paper 5

Room B
13:50-14:05 Keynote Lecture. Single-Cell Transcriptome Analysis to Uncover Mechanisms of Metastasis in Pancreaticobiliary Cancers
Semin Lee (UNIST, Korea)
Symposium 5.
April 4 (Sat)
13:50-15:20

Symposium 5.
Innovative Strategies to Overcome Therapeutic Challenges in Pancreatobiliary Cancers

Room C
13:50-14:10 Reprogramming the Tumor Microenvironment: Activating Anti-Tumor Functions of Cancer-Associated Fibroblasts in Pancreatic Cancer
Daniel Öhlund (Umeå University, Sweden)
14:10-14:30 Optimizing Cytotoxic Chemotherapy: Combining and Sequencing Strategies in Pancreatic Cancer
Dong Kee Jang (Seoul National University, Korea)
14:30-14:50 Evolving Paradigms in Biliary Tract Cancers: Immune Checkpoint Inhibition and Precision Medicine
Dong Wook Lee (Kyungpook National University, Korea)
14:50-15:10 Personalized mRNA Vaccines: Current Status and Future Prospects in Pancreatobiliary Cancers
Kyu-Pyo Kim (University of Ulsan, Korea)
15:10-15:20 Q&A
WEO Joint Symposium
April 4 (Sat)
15:40-17:10

WEO Joint Symposium

Room A
15:40-16:00
Jong Ho Moon (SoonChunHyang University, Korea)
16:00-16:20 Role of endoscopy in indeterminate strictures
Lars Aabakken (Oslo University Hospital, Norway)
16:20-16:40 Advances in biliary and gallbladder drainage: when at first you don't succeed
Douglas Faigel (Mayoclinic, USA)
16:40-17:00 Post ERCP Pancreatitis
D Nageshwar Reddy (AIG Hospitals, India)
17:00-17:10 Q&A
Free Paper 6
April 4 (Sat)
15:40-17:10

Free Paper 6

Room B
15:40-15:55 Keynote Lecture 1
Hsiu-Po Wang (National Taiwan University Hospital, Taiwan)
Symposium 6.
April 4 (Sat)
15:40-17:10

Symposium 6.
Controversies and Consensus in Biliary Interventions

Room C
15:40-16:00 ERCP vs EUS-BD as First-line: Should We Change the Paradigm?
Hideyuki Shiomi (Hyogo Medical University, Japan)
16:00-16:20 Unresectable Hilar Cholangiocarcinoma: Endoscopic vs Percutaneous
Tae Hoon Lee (SoonChunHyang University, Korea)
16:20-16:40 RFA Ablation Duration (60 vs 90 vs 120s): What's Optimal?
Jae Hee Cho (Yonsei University, Korea)
16:40-17:00 Combined ERCP and EUS: One-session, Two-scope Strategy — Is It Practical?
TBD
17:00-17:10 Q&A